Buscar en
Revista Española de Patología
Toda la web
Inicio Revista Española de Patología Lesiones histológicas de riesgo de carcinoma de mama. Guía de supervivencia pa...
Journal Information
Vol. 53. Issue 3.
Pages 158-166 (July - September 2020)
Share
Share
Download PDF
More article options
Visits
552
Vol. 53. Issue 3.
Pages 158-166 (July - September 2020)
REVISIÓN
Lesiones histológicas de riesgo de carcinoma de mama. Guía de supervivencia para el patólogo general
Histological lesions of risk of breast carcinoma. Survival guide for the general pathologist
Visits
552
Vicente Marco Molina
Corresponding author
vmarcomolina@gmail.com

Autor para correspondencia.
, Felip García Hernández
Servicio de Anatomía Patológica, Hospital Quirónsalud Barcelona, Barcelona, España
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Tables (3)
Tabla 1. Clasificación de las lesiones mamarias de riesgo
Tabla 2. Manejo de las lesiones mamarias de riesgo diagnosticadas mediante biopsia con aguja gruesa
Tabla 3. Sistema de clasificación diagnóstica de las biopsias con aguja gruesa
Show moreShow less
Resumen

Las lesiones histológicas de riesgo de cáncer de mama son lesiones epiteliales proliferativas. Constituyen un grupo heterogéneo de lesiones con distinta magnitud de riesgo, en relación con la presencia de atipia. Plantean el diagnóstico diferencial con lesiones benignas, carcinoma ductal in situ y carcinoma infiltrante. El diagnóstico histológico correcto es importante, ya que plantea distintas opciones terapéuticas, incluyendo biopsias asistida por vacío y cirugía. Revisamos los criterios diagnósticos y el diagnóstico diferencial de la hiperplasia ductal usual, la cicatriz radial y las lesiones esclerosantes complejas, las adenosis de distinto tipo, las lesiones papilares, la hiperplasia ductal atípica, la atipia epitelial plana y la neoplasia lobulillar in situ. Asimismo, recogemos la magnitud de riesgo asociada a las diversas entidades y las posibles opciones de manejo.

Palabras clave:
Lesiones de riesgo
Neoplasia de mama
Carcinoma
Hiperplasia
Carcinoma lobulillar in situ
Abstract

Proliferative epithelial lesions are risk factors for breast cancer. They are a heterogeneous group of lesions in which the presence of atypia is related to varying degrees of risk. They should be considered in the differential diagnosis with benign lesions, in situ ductal carcinoma and infiltrating carcinoma. An accurate histopathological diagnosis is important in choosing the best therapeutic option, including vacuum assisted biopsy and surgery. We revise diagnostic criteria and the differential diagnosis of usual ductal hyperplasia, radial scar and complex sclerosing lesions, distinct types of adenosis, papillary lesions, atypical ductal hyperplasia, flat epithelial atypia and lobular neoplasia in situ. Furthermore, we summarize the degree of risk associated with the different conditions and management possibilities.

Keywords:
Risk lesions
Breast neoplasm
Carcinoma
Hyperplasia
Lobular carcinoma in situ

Article

These are the options to access the full texts of the publication Revista Española de Patología
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Patología

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos